ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Cell

• Publication date

  2010-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2010.02.030PMID 20385358PMCID PMC2881822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.

  2009cited by this paper
• miR‐200 Regulates PDGF‐D‐Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells

  2009cited by this paper
• Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

  2009cited by this paper
• Hypoxia‐inducible factor 1α activates and is inhibited by unoccupied estrogen receptor β

  2009cited by this paper
• Mortality results from a randomized prostate-cancer screening trial.

  2009cited by this paper
• Prostate Cancer With Tertiary Gleason Pattern 5 in Prostate Needle Biopsy: Clinicopathologic Findings and Disease Progression

  2009cited by this paper
• Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

  2009cited by this paper
• Screening and prostate-cancer mortality in a randomized European study.

  2009cited by this paper
• Analytical And Quantitativecytology And Histology From The Volumr 30, Number 5, October 2008

  2008cited by this paper
• The role of estrogens and estrogen receptors in normal prostate growth and disease.

  2008cited by this paper
• Blocking neuropilin-2 function inhibits tumor cell metastasis.

  2008cited by this paper
• Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression.

  2008cited by this paper
• Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues

  2008cited by this paper
• Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes.

  2008influential reference
• Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

  2008cited by this paper
• Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation.

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2*

  2008cited by this paper
• A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

  2007influential reference
• 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.

  2007cited by this paper
• uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells

  2007cited by this paper
• 5α-Androstane-3β,17β-diol (3β-diol), an estrogenic metabolite of 5α-dihydrotestosterone, is a potent modulator of estrogen receptor ERβ expression in the ventral prostrate of adult rats

  2007cited by this paper
• The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

  2007cited by this paper
• Hypoxia: A key regulator of angiogenesis in cancer

  2007cited by this paper
• Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.

  2007cited by this paper
• Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

  2007cited by this paper
• Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

  2007influential reference
• Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

  2007cited by this paper
• Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

  2006cited by this paper
• The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.

  2006cited by this paper
• The neuropilins and their role in tumorigenesis and tumor progression.

  2006cited by this paper
• Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

  2006cited by this paper
• Words of wisdom. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

  2006cited by this paper
• A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

  2006cited by this paper
• Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.

  2006cited by this paper
• Apigenin suppresses cancer cell growth through ERbeta.

  2006cited by this paper
• Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling

  2006cited by this paper
• The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2005cited by this paper
• Wnt-dependent Regulation of the E-cadherin Repressor Snail*

  2005cited by this paper
• VEGF as a Therapeutic Target in Cancer

  2005cited by this paper
• The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.

  2005cited by this paper
• Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription

  2005cited by this paper
• The transcriptional repressor Snail promotes mammary tumor recurrence.

  2005influential reference
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004influential reference
• Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

  2004cited by this paper
• Estrogen Receptor-Beta Regulates Epithelial Cell Differentiation in the Mouse Ventral Prostate

  2004cited by this paper
• Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

  2004cited by this paper
• Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

  2004cited by this paper
• Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins

  2004cited by this paper
• Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate

  2004cited by this paper
• Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.

  2004cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003cited by this paper
• Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids.

  2003cited by this paper
• Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer.

  2003cited by this paper
• Phosphorylation Regulates the Subcellular Location and Activity of the Snail Transcriptional Repressor

  2003cited by this paper
• MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.

  2003cited by this paper
• Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.

  2003cited by this paper
• Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

  2003cited by this paper
• Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

  2002cited by this paper
• Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer.

  2001cited by this paper
• Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer

  2001cited by this paper
• Frequent loss of estrogen receptor-beta expression in prostate cancer.

  2001cited by this paper
• Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

  2001cited by this paper
• Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

  2001influential reference
• Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma

  2001influential reference
• Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression

  2000cited by this paper
• Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

  2000cited by this paper
• VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms

  2000cited by this paper
• Cadherin switching in human prostate cancer progression.

  2000influential reference
• The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

  1999cited by this paper
• Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

  1998influential reference
• Estrogen Receptor- b Messenger Ribonucleic Acid Ontogeny in the Prostate of Normal and Neonatally Estrogenized Rats*

  1998cited by this paper
• Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion.

  1997influential reference
• The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens

  1997cited by this paper
• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  1997cited by this paper
• Intratissular androgens in benign prostatic hyperplasia and prostatic cancer.

  1986cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper

• Squalene synthase induces ERα expression via cholesterol supplementation to confer statin resistance in lung cancer cells.

  2026cites this paper
• The Role of Estrogen Signaling Pathway and Targeted Therapy Exploration in Urological Tumors

  2026cites this paper
• The Role of Heavy Metals in the Biology of Female Cancers

  2025cites this paper
• Candida albicans drives colorectal cancer progression by inducing hypoxia signaling

  2025cites this paper
• THSD7A as a novel prognostic factor for colorectal carcinoma

  2025cites this paper
• HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment

  2025cites this paper
• Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway

  2025cites this paper
• Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1–SNAI1 axis

  2024cites this paper
• The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors

  2024cites this paper
• Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review)

  2024cites this paper
• Associations of the Expression Levels and Risk Variants of CDKN2B‐AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer

  2024cites this paper
• Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities.

  2024cites this paper
• Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment

  2024cites this paper
• Genes Co-Expressed with ESR2 Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis

  2024cites this paper
• Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting

  2023cites this paper
• Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function

  2023cites this paper
• Molecular mechanisms of microRNA-301a during tumor progression and metastasis.

  2023cites this paper
• Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer

  2023cites this paper
• WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer

  2023cites this paper
• Extracellular Succinate: A Physiological Messenger and a Pathological Trigger

  2023cites this paper
• Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

  2023cites this paper
• A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities

  2023cites this paper
• PrLZ regulates EMT and invasion in prostate cancer via the TGF‐β1/p‐smad2/miR‐200 family/ZEB1 axis

  2023cites this paper
• Prognostic value of estrogen receptors in patients who underwent prostatectomy for non‑metastatic prostate cancer.

  2023cites this paper
• Plumbagin Nanoliposomes Suppress HepG2 Cell Proliferation, Migration, and Invasion by Accelerating miR-16-5p Expression and Inhibiting the VEGFA/EMT Pathway

  2023cites this paper
• Complex Extract of Polygonatum sibiricum and Nelumbinis semen Improves Menopause Symptoms via Regulation of Estrogen Receptor Beta in an Ovariectomized Rat Model

  2023cites this paper
• Estrogen Receptor β Isoforms Regulate Chemotherapy Resistance and the Cancer Stem Cell Population in Prostate Cancer Cells

  2023cites this paper
• Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer

  2023cites this paper
• Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.

  2023cites this paper
• The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches

  2023influential citation
• Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis

  2023cites this paper
• Travelling under pressure - hypoxia and shear stress in the metastatic journey

  2023cites this paper
• Transición epitelio – mesenquima y cáncer.

  2023cites this paper
• Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction

  2023cites this paper
• An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?

  2022influential citation
• AMPK’s double-faced role in advanced stages of prostate cancer

  2022cites this paper
• Silencing of OGDHL promotes liver cancer metastasis by enhancing hypoxia inducible factor 1 α protein stability

  2022cites this paper
• ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery

  2022cites this paper
• Cancer-derived extracellular succinate: a driver of cancer metastasis

  2022cites this paper
• Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer

  2022cites this paper
• Signal Crosstalk and the Role of Estrogen Receptor beta (ERβ) in Prostate Cancer

  2022cites this paper
• Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling

  2022cites this paper
• Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain

  2022cites this paper
• A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition

  2022cites this paper
• Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation

  2022cites this paper
• Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment

  2022cites this paper
• Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist

  2022cites this paper
• Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway

  2022influential citation
• ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition

  2022cites this paper
• Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate

  2021influential citation
• Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation.

  2021cites this paper
• Hypoxia and the phenomenon of immune exclusion

  2021cites this paper
• [A Review of High-altitude Hypoxia Adaptation and Hypoxic Solid Tumor].

  2021cites this paper
• Androgens in prostate cancer: A tale that never ends.

  2021cites this paper
• Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer

  2021cites this paper
• miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1

  2021cites this paper
• Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA

  2021cites this paper
• OTT_A_310198 3729..3737

  2021cites this paper
• Estrogen receptor β in cancer: to β(e) or not to β(e)?

  2021cites this paper
• 4.1N-Mediated Interactions and Functions in Nerve System and Cancer

  2021cites this paper
• Understanding the Components of EMT Proteome and Their Regulations to Identify Biomarkers for Cancer Prognosis

  2021cites this paper
• Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients

  2021cites this paper
• Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors

  2021cites this paper
• MiR-195 inhibits the ubiquitination and degradation of YY1 by Smurf2, and induces EMT and cell permeability of retinal pigment epithelial cells

  2021cites this paper
• Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer

  2020cites this paper
• PCAF‐mediated acetylation of ISX recruits BRD4 to promote epithelial‐mesenchymal transition

  2020cites this paper
• Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments

  2020cites this paper
• Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology

  2020cites this paper
• Antitumor effects of aconitine in A2780 cells via estrogen receptor β-mediated apoptosis, DNA damage and migration

  2020cites this paper
• LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis

  2020cites this paper
• NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.

  2020cites this paper
• Molecular tracing of prostate cancer lethality

  2020cites this paper
• Identi cation And Validation Of A Hypoxia ‐ Related Prognostic Signature In Clear Cell Renal Cell Carcinoma Patients

  2020cites this paper
• Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells.

  2020cites this paper
• SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis

  2020cites this paper
• 4‐nitrophenol exposure in T24 human bladder cancer cells promotes proliferation, motilities, and epithelial‐to‐mesenchymal transition

  2020cites this paper
• MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer

  2020cites this paper
• Isolation and Characterization of Phenylpropanoid and Lignan Compounds from Peperomia pellucida [L.] Kunth with Estrogenic Activities

  2020cites this paper
• Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy

  2020cites this paper
• Long Non-coding RNA PTCSC3 Promotes Apoptosis of Human Papillary Thyroid Carcinomas by Regulating S100A4

  2020cites this paper
• Hypoxia and cancer related pathology.

  2020cites this paper
• Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine

  2020cites this paper
• Unresolved Complexity in the Gene Regulatory Network Underlying EMT

  2020cites this paper
• Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy

  2020cites this paper
• Critical Steps in Epithelial-Mesenchymal Transition as Target for Cancer Treatment

  2020cites this paper
• Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1α

  2020cites this paper
• A synthetic coumarin derivative (4‐flourophenylacetamide‐acetyl coumarin) impedes cell cycle at G0/G1 stage, induces apoptosis, and inhibits metastasis via ROS‐mediated p53 and AKT signaling pathways in A549 cells

  2020cites this paper
• Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis

  2020cites this paper
• Enhanced identification of significant regulators of gene expression

  2020cites this paper
• Oestrogen receptors and hypoxia inducible factor 1 alpha expression in abdominal wall endometriosis.

  2020cites this paper
• Size, site, and signaling: Three attributes of estrogen receptors

  2019cites this paper
• Targeting Wistar rat as a model for studying benign, premalignant and malignant lesions of the prostate.

  2019cites this paper
• Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes

  2019cites this paper
• Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.

  2019cites this paper
• Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer

  2019influential citation
• Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization

  2019cites this paper
• Hypoxia-related miR-2105 p and miR-2103 p regulate hypoxia-induced migration and epithelial-mesenchymal transition in hepatoma cells

  2019cites this paper
• Transcriptional regulation of FoxM1 by HIF-1α mediates hypoxia-induced EMT in prostate cancer

  2019cites this paper
• H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer

  2019cites this paper
• VEGF/Neuropilin Signaling in Cancer Stem Cells

  2019cites this paper